Division of Pediatric Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, St Louis, MO 63110-1093, USA.
J Allergy Clin Immunol. 2012 Jul;130(1):91-100.e3. doi: 10.1016/j.jaci.2012.02.010. Epub 2012 Mar 22.
The development of asthma after respiratory syncytial virus (RSV) bronchiolitis has been demonstrated in case-control studies, although the determinants of post-RSV asthma remain undefined.
We sought to evaluate the potential determinants of physician-diagnosed asthma after severe RSV bronchiolitis during infancy.
We enrolled 206 children during an initial episode of severe RSV bronchiolitis at 12 months of age or less in a prospective cohort study and followed these children for up to 6 years. In a subset of 81 children, we analyzed CCL5 (RANTES) mRNA expression in upper airway epithelial cells.
Forty-eight percent of children had physician-diagnosed asthma before the seventh birthday. Independent determinants significantly associated with increased risk for physician-diagnosed asthma by the seventh birthday included maternal asthma (odds ratio [OR], 5.2; 95% CI, 1.7-15.9; P = .004), exposure to high levels of dog allergen (OR, 3.2; 95% CI, 1.3-7.7; P = .012), aeroallergen sensitivity at age 3 years (OR, 10.7; 95% CI, 2.1-55.0; P = .005), recurrent wheezing during the first 3 years of life (OR, 7.3; 95% CI, 1.2-43.3; P = .028), and CCL5 expression in nasal epithelia during acute RSV infection (OR, 3.8; 95% CI, 1.2-2.4; P < .001). White children (OR, 0.19; 95% CI, 0.04-0.93; P = .041) and children attending day care (OR, 0.18; 95% CI, 0.04-0.84; P = .029) had a decreased risk of physician-diagnosed asthma.
Approximately 50% of children who experience severe RSV bronchiolitis have a subsequent asthma diagnosis. The presence of increased CCL5 levels in nasal epithelia at the time of bronchiolitis or the development of allergic sensitization by age 3 years are associated with increased likelihood of subsequent asthma.
在病例对照研究中已经证实,呼吸道合胞病毒(RSV)毛细支气管炎后会发展为哮喘,但 RSV 后哮喘的决定因素仍未确定。
我们旨在评估婴儿期重度 RSV 毛细支气管炎后医生诊断为哮喘的潜在决定因素。
我们在一项前瞻性队列研究中纳入了 206 名 12 个月或以下初次发生严重 RSV 毛细支气管炎的儿童,并对这些儿童进行了长达 6 年的随访。在 81 名儿童的亚组中,我们分析了上呼吸道上皮细胞中 CCL5(RANTES)mRNA 的表达。
48%的儿童在 7 岁生日前被诊断为哮喘。到 7 岁时,与哮喘风险增加显著相关的独立决定因素包括母亲哮喘(比值比[OR],5.2;95%可信区间[CI],1.7-15.9;P=.004)、高水平的狗过敏原暴露(OR,3.2;95% CI,1.3-7.7;P=.012)、3 岁时变应原敏感性(OR,10.7;95% CI,2.1-55.0;P=.005)、生命最初 3 年反复喘息(OR,7.3;95% CI,1.2-43.3;P=.028)和急性 RSV 感染期间鼻上皮细胞的 CCL5 表达(OR,3.8;95% CI,1.2-2.4;P <.001)。白人儿童(OR,0.19;95% CI,0.04-0.93;P=.041)和上日托的儿童(OR,0.18;95% CI,0.04-0.84;P=.029)患医生诊断的哮喘的风险降低。
约 50%经历严重 RSV 毛细支气管炎的儿童随后会被诊断为哮喘。毛细支气管炎时鼻上皮细胞中 CCL5 水平升高或 3 岁时出现变应原致敏与随后发生哮喘的可能性增加相关。